We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

4 hedge funds and large institutions have $9.75M invested in Altamira Therapeutics Ltd in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

26% more capital invested

Capital invested by funds: $7.74M → $9.75M (+$2.01M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $17K

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
$17K
Net Calls
-$17K
Net Calls Change
+$23K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$1.59M
2
Citadel Advisors
Citadel Advisors
Florida
-$18K
3
Citigroup
Citigroup
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SMV
1
Sofinnova Management VIII
California
$6.22M +$7.24M +73 New
BG
2
Bellevue Group
Switzerland
$2.32M – – –
TCM
3
Tekla Capital Management
Massachusetts
$829K – – –
WA
4
Wasatch Advisors
Utah
$124K -$1.59M -16 -94%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$36K – – –
CS
6
Credit Suisse
Switzerland
$31K – – –
Goldman Sachs
7
Goldman Sachs
New York
$25K – – –
KeyBank National Association
8
KeyBank National Association
Ohio
$25K – – –
Millennium Management
9
Millennium Management
New York
$25K – – –
VKH
10
Virtu KCG Holdings
New York
$22K – – –
SPC
11
Sigma Planning Corp
Michigan
$19K – – –
WS
12
Wedbush Securities
California
$19K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$17K – – –
CG
14
Cutler Group
California
$15K – – –
AIM
15
Acrospire Investment Management
Illinois
$13K – – –
Group One Trading
16
Group One Trading
Illinois
$4K – – –
Creative Planning
17
Creative Planning
Kansas
$1K – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$18K – –
Citigroup
19
Citigroup
New York
– -$3K – –

CYTO Hedge Fund Activity: Q4 2016 in Review

4 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2016, worth a combined $9.75M — up 26% from $7.74M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CYTO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest seller was Wasatch Advisors, cutting an estimated $1.59M.

  • 4 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2016, up from 3 in Q3 2016.
  • Funds reported $9.75M of Altamira Therapeutics Ltd stock for Q4 2016, up 26% quarter-over-quarter.
  • 1 fund opened new Altamira Therapeutics Ltd positions in Q4 2016 and 0 closed out, a net change of +1 holder.
  • The largest Altamira Therapeutics Ltd seller in Q4 2016 was Wasatch Advisors, an estimated $1.59M sold.

Based on aggregated 13F filings for Q4 2016.